Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / COVID-19 - Page 69

COVID-19

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza

On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…

Read More Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenzaContinue

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore
COVID-19 | Life Science History

Philanthropic gifts funded COVID-19 pilot research projects at Einstein and Montefiore

On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…

Read More Philanthropic gifts funded COVID-19 pilot research projects at Einstein and MontefioreContinue

AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies
Biotechnology | COVID-19 | Diagnostics

AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodies

On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…

Read More AXIM Biotechnologies unveiled first-in-class COVID-19 rapid diagnostic test for neutralizing antibodiesContinue

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility
Biotechnology | COVID-19 | Diagnostics | Genomics | Non-Profit Research

Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibility

On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….

Read More Cleveland Clinic researchers Identified genetic factors that may Influence COVID-19 susceptibilityContinue

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2
Biotechnology | COVID-19 | Therapeutics

Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2

On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…

Read More Atossa Therapeutics announced successful in vitro testing of nasal spray formulation with SARS-CoV-2Continue

WHO and UNICEF warn of a decline in vaccinations during COVID-19
COVID-19 | Life Science History | Vaccine | WHO

WHO and UNICEF warn of a decline in vaccinations during COVID-19

On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…

Read More WHO and UNICEF warn of a decline in vaccinations during COVID-19Continue

More than 150 countries engaged in COVID-19 vaccine global access facility
COVID-19 | Non-Profit Research | Vaccine

More than 150 countries engaged in COVID-19 vaccine global access facility

On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…

Read More More than 150 countries engaged in COVID-19 vaccine global access facilityContinue

BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked
Biotechnology | COVID-19 | Diagnostics

BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE marked

On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…

Read More BIOFIRE respiratory panel 21 plus with SARS-CoV-2 was CE markedContinue

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19
Biotechnology | COVID-19 | Therapeutics

Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19

On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…

Read More Akebia announced initiation of investigator-sponsored study evaluating vadadustat for prevention and treatment of ARDS in patients with COVID-19Continue

Experimental COVID-19 vaccine safe, generated immune response
Biotechnology | COVID-19 | Non-Profit Research | Vaccine

Experimental COVID-19 vaccine safe, generated immune response

On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…

Read More Experimental COVID-19 vaccine safe, generated immune responseContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

CDC called on Americans to wear masks to prevent COVID-19 spread
CDC | COVID-19 | Life Science History

CDC called on Americans to wear masks to prevent COVID-19 spread

On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…

Read More CDC called on Americans to wear masks to prevent COVID-19 spreadContinue

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2
COVID-19 | Life Science History | Vaccine

HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2

On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…

Read More HKUMed researchers mined immunogenic information from SARS-CoV-2 for rational design of vaccine against SARS-CoV-2Continue

Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA
COVID-19 | Life Science History | Vaccine

Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPA

On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…

Read More Fosun announced COVID-19 vaccine product received acceptance notice of clinical trial application by NMPAContinue

Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia
COVID-19 | Life Science History

Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumonia

On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…

Read More Rigel announces investigator-sponsored trial of fostamatinib in patients with COVID-19 pneumoniaContinue

Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidate
COVID-19 | FDA | Life Science History

Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidate

On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…

Read More Dynavax announced first participants dosed in phase 1 clinical evaluating Medicagoメs COVID-19 vaccine candidateContinue

Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19

On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…

Read More Moderna announced publication in The New England Journal of Medicine of interim results from phase 1 study of its mRNA vaccine against COVID-19Continue

Pascal Biosciences discovered a cannabinoid that combats Coronavirus
Biotechnology | COVID-19 | Infectious Disease | Medicine | Therapeutics

Pascal Biosciences discovered a cannabinoid that combats Coronavirus

On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…

Read More Pascal Biosciences discovered a cannabinoid that combats CoronavirusContinue

Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays
COVID-19 | Life Science History

Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assays

On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…

Read More Meridian Bioscience launched high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for development of rapid COVID-19 antigen assaysContinue

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths
COVID-19 | Life Science History | NIH | Vaccine

Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deaths

On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…

Read More Preliminary study suggested tuberculosis vaccine may be limiting COVID-19 deathsContinue

Province of Alberta made 20 million masks available free of charge
COVID-19

Province of Alberta made 20 million masks available free of charge

On Jul. 13, 2020, 20 million masks were made available at more than 700 partner restaurant locations, including…

Read More Province of Alberta made 20 million masks available free of chargeContinue

Engineered llama antibodies neutralised Covid-19 virus
COVID-19 | Life Science History | Nanotechnology

Engineered llama antibodies neutralised Covid-19 virus

On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…

Read More Engineered llama antibodies neutralised Covid-19 virusContinue

Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sites
COVID-19 | Life Science History

Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sites

On Jul. 13, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced the enrollment of adult patients for…

Read More Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sitesContinue

Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter
COVID-19 | Life Science History

Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarter

On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…

Read More Innovation Pharma’s clinical trial testing of brilacidin against COVID-19 targeted to commence in 2020 fourth quarterContinue

Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDル
COVID-19 | Life Science History | Vaccine

Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDル

On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…

Read More Altimmune and University of Alabama at Birmingham announced positive preclinical results for intranasal COVID-19 vaccine candidate, AdCOVIDルContinue

Bellerophon Therapeutics announced first patient treated in phase 3 clinical study of INOpulseᆴ inhaled nitric oxide therapy for COVID-19
COVID-19 | FDA | Life Science History

Bellerophon Therapeutics announced first patient treated in phase 3 clinical study of INOpulseᆴ inhaled nitric oxide therapy for COVID-19

On Jul. 13, 2020, Bellerophon Therapeutics announced that the first patient has initiated treatment in the Companyメs Phase…

Read More Bellerophon Therapeutics announced first patient treated in phase 3 clinical study of INOpulseᆴ inhaled nitric oxide therapy for COVID-19Continue

Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2
COVID-19 | FDA | Life Science History

Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2

On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesメ four investigational vaccine candidates from…

Read More Pfizer and BioNTech granted FDA Fast Track Designation for two investigational mRNA-based vaccine candidates against SARS-CoV-2Continue

OPKO Health’s BioReference Laboratories to provide COVID-19 testing for National Basketball Association players and employees
COVID-19 | Life Science History

OPKO Health’s BioReference Laboratories to provide COVID-19 testing for National Basketball Association players and employees

On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight…

Read More OPKO Health’s BioReference Laboratories to provide COVID-19 testing for National Basketball Association players and employeesContinue

Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19
Biotechnology | COVID-19 | Infectious Disease | Influenza | Vaccine

Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19

On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…

Read More Tonix Pharma entered into research and exclusive license option agreement with Kansas State University to develop vaccine against COVID-19Continue

Philips launched obstetrics monitoring solution to support clinicians and expectant mothers during COVID-19 pandemic
COVID-19 | Life Science History

Philips launched obstetrics monitoring solution to support clinicians and expectant mothers during COVID-19 pandemic

On Jul. 12, 2020, Royal Philips announced an addition to its remote patient monitoring suite supporting at-risk populations…

Read More Philips launched obstetrics monitoring solution to support clinicians and expectant mothers during COVID-19 pandemicContinue

Page navigation

Previous PagePrevious 1 … 67 68 69 70 71 … 99 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cardiology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemistry
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Banner Advertising

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search